SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-21-019899
Filing Date
2021-08-16
Accepted
2021-08-16 07:00:47
Documents
28
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form6-k.htm   iXBRL 6-K 465163
  Complete submission text file 0001493152-21-019899.txt   1892844

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vblt-20210630.xsd EX-101.SCH 14667
3 XBRL CALCULATION FILE vblt-20210630_cal.xml EX-101.CAL 36441
4 XBRL DEFINITION FILE vblt-20210630_def.xml EX-101.DEF 45046
5 XBRL LABEL FILE vblt-20210630_lab.xml EX-101.LAB 172093
6 XBRL PRESENTATION FILE vblt-20210630_pre.xml EX-101.PRE 118326
7 EXTRACTED XBRL INSTANCE DOCUMENT form6-k_htm.xml XML 113874
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36581 | Film No.: 211174442
SIC: 2834 Pharmaceutical Preparations